|
ZNF643 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62436730732907E-12 |
| Normal-vs-Stage2 |
2.633800E-04 |
| Normal-vs-Stage3 |
2.59769983301794E-11 |
| Normal-vs-Stage4 |
1.45899999859367E-08 |
| Stage1-vs-Stage2 |
2.809000E-01 |
| Stage1-vs-Stage3 |
3.270800E-01 |
| Stage1-vs-Stage4 |
7.187400E-01 |
| Stage2-vs-Stage3 |
7.051000E-01 |
| Stage2-vs-Stage4 |
4.980000E-01 |
| Stage3-vs-Stage4 |
6.511600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.019200E-03 |
| Normal-vs-Asian |
4.26659996222156E-09 |
| Caucasian-vs-AfricanAmerican |
5.445200E-01 |
| Caucasian-vs-Asian |
3.151000E-01 |
| AfricanAmerican-vs-Asian |
2.339200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68149954965702E-11 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.762300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62470037423645E-12 |
| Normal-vs-Age(61-80Yrs) |
1.14630000047633E-07 |
| Normal-vs-Age(81-100Yrs) |
4.568800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.056600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.779900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.551600E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.974200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.858300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.144810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.880400E-01 |
| Classical-VS-Follicular |
4.9960036108132E-15 |
| Classical-VS-Other |
6.476000E-02 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.55950000005445E-06 |
| Tall-VS-Other |
4.388400E-02 |
| Tall-VS-Normal |
1.49059999898782E-08 |
| Follicular-VS-Other |
6.698200E-01 |
| Follicular-VS-Normal |
6.483900E-02 |
| Other-VS-Normal |
3.728400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.17992290885149E-12 |
| Normal-vs-N1 |
2.70900000209906E-08 |
| N0-vs-N1 |
4.802600E-01 |
|
|
